INFLARX NV (IFRX) Stock Fundamental Analysis

NASDAQ:IFRX • NL0012661870

0.9048 USD
+0.03 (+3.67%)
Last: Feb 20, 2026, 11:59 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, IFRX scores 2 out of 10 in our fundamental rating. IFRX was compared to 521 industry peers in the Biotechnology industry. IFRX may be in some trouble as it scores bad on both profitability and health. IFRX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year IFRX has reported negative net income.
  • In the past year IFRX has reported a negative cash flow from operations.
  • IFRX had negative earnings in each of the past 5 years.
  • IFRX had a negative operating cash flow in each of the past 5 years.
IFRX Yearly Net Income VS EBIT VS OCF VS FCFIFRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • The Return On Assets of IFRX (-61.55%) is comparable to the rest of the industry.
  • The Return On Equity of IFRX (-88.40%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -61.55%
ROE -88.4%
ROIC N/A
ROA(3y)-41.63%
ROA(5y)-39.97%
ROE(3y)-49.99%
ROE(5y)-47.39%
ROIC(3y)N/A
ROIC(5y)N/A
IFRX Yearly ROA, ROE, ROICIFRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IFRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IFRX Yearly Profit, Operating, Gross MarginsIFRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • IFRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IFRX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, IFRX has more shares outstanding
  • The debt/assets ratio for IFRX is higher compared to a year ago.
IFRX Yearly Shares OutstandingIFRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IFRX Yearly Total Debt VS Total AssetsIFRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • IFRX has an Altman-Z score of -6.79. This is a bad value and indicates that IFRX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -6.79, IFRX is not doing good in the industry: 64.88% of the companies in the same industry are doing better.
  • IFRX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.02, IFRX is in line with its industry, outperforming 44.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -6.79
ROIC/WACCN/A
WACC7.36%
IFRX Yearly LT Debt VS Equity VS FCFIFRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • IFRX has a Current Ratio of 3.33. This indicates that IFRX is financially healthy and has no problem in meeting its short term obligations.
  • IFRX's Current ratio of 3.33 is in line compared to the rest of the industry. IFRX outperforms 40.12% of its industry peers.
  • IFRX has a Quick Ratio of 3.06. This indicates that IFRX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of IFRX (3.06) is worse than 61.42% of its industry peers.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 3.06
IFRX Yearly Current Assets VS Current LiabilitesIFRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • IFRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.78%, which is quite impressive.
  • IFRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.49%.
EPS 1Y (TTM)38.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)-62.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-80.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.32% on average over the next years. This is quite good.
  • IFRX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 99.39% yearly.
EPS Next Y12.2%
EPS Next 2Y5.93%
EPS Next 3Y0.25%
EPS Next 5Y11.32%
Revenue Next Year-77.89%
Revenue Next 2Y59.75%
Revenue Next 3Y77.94%
Revenue Next 5Y99.39%

3.3 Evolution

IFRX Yearly Revenue VS EstimatesIFRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2020 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
IFRX Yearly EPS VS EstimatesIFRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IFRX. In the last year negative earnings were reported.
  • Also next year IFRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IFRX Price Earnings VS Forward Price EarningsIFRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IFRX Per share dataIFRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.93%
EPS Next 3Y0.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IFRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INFLARX NV

NASDAQ:IFRX (2/20/2026, 11:59:36 AM)

0.9048

+0.03 (+3.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)03-18
Inst Owners27.51%
Inst Owner Change6.52%
Ins Owners6.38%
Ins Owner ChangeN/A
Market Cap61.30M
Revenue(TTM)63.20K
Net Income(TTM)-40.10M
Analysts81.43
Price Target10.93 (1108%)
Short Float %5.02%
Short Ratio5.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.91%
Min EPS beat(2)-16.54%
Max EPS beat(2)-11.29%
EPS beat(4)2
Avg EPS beat(4)17.88%
Min EPS beat(4)-16.54%
Max EPS beat(4)68.63%
EPS beat(8)3
Avg EPS beat(8)1.85%
EPS beat(12)7
Avg EPS beat(12)12.99%
EPS beat(16)10
Avg EPS beat(16)16.59%
Revenue beat(2)0
Avg Revenue beat(2)-45.63%
Min Revenue beat(2)-67.47%
Max Revenue beat(2)-23.79%
Revenue beat(4)0
Avg Revenue beat(4)-73.03%
Min Revenue beat(4)-100.86%
Max Revenue beat(4)-23.79%
Revenue beat(8)1
Avg Revenue beat(8)-66.61%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.41%
PT rev (3m)158.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 825.27
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS0
BVpS0.79
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.55%
ROE -88.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-41.63%
ROA(5y)-39.97%
ROE(3y)-49.99%
ROE(5y)-47.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.73%
Cap/Sales 206.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.33
Quick Ratio 3.06
Altman-Z -6.79
F-Score1
WACC7.36%
ROIC/WACCN/A
Cap/Depr(3y)17.06%
Cap/Depr(5y)14.01%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y12.2%
EPS Next 2Y5.93%
EPS Next 3Y0.25%
EPS Next 5Y11.32%
Revenue 1Y (TTM)-62.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-80.65%
Revenue Next Year-77.89%
Revenue Next 2Y59.75%
Revenue Next 3Y77.94%
Revenue Next 5Y99.39%
EBIT growth 1Y20.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.13%
EBIT Next 3Y1.81%
EBIT Next 5YN/A
FCF growth 1Y-31.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.19%
OCF growth 3YN/A
OCF growth 5YN/A

INFLARX NV / IFRX FAQ

Can you provide the ChartMill fundamental rating for INFLARX NV?

ChartMill assigns a fundamental rating of 2 / 10 to IFRX.


What is the valuation status of INFLARX NV (IFRX) stock?

ChartMill assigns a valuation rating of 0 / 10 to INFLARX NV (IFRX). This can be considered as Overvalued.


Can you provide the profitability details for INFLARX NV?

INFLARX NV (IFRX) has a profitability rating of 1 / 10.


How financially healthy is INFLARX NV?

The financial health rating of INFLARX NV (IFRX) is 3 / 10.